April 21, 2026
The molecule therapeutics market is growing due to the field of molecular therapeutics is significant in medicine and human biology, as it provides novel information on the discovery, diagnosis, and treatment of present and emerging diseases....
April 21, 2026
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key playe...
April 21, 2026
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market ...
April 21, 2026
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North A...
April 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
February 11, 2026
According to our projections, the global small molecule CMC service market was valued at USD 801.3 million in 2025 and reached USD 831.35 million in 2026, and it is projected to expand to approximately USD 1,157.91 million by 2035, growing at a CAGR ...
April 21, 2026
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 202...
June 23, 2026
According to Rohan Patil, who specializes in pharmaceutical outsourcing, drug discovery services, and life sciences market research, with 5+ years of experience in market research and industry analysis. My research indicates that the Small Molecule D...
June 16, 2026
According to Rohan Patil, who specializes in pharmaceutical CDMO, life sciences, and healthcare market analysis, with 5+ years of experience in market research and industry analysis, his research reveals that the U.S. Small Molecule Innovator API CDM...
May 21, 2026
Small Molecule Innovator API CDMO Market (By Stage Type: Preclinical, Clinical, Phase I, Phase II, Phase III, Commercial; By Customer Type: Pharmaceutical, Small, Medium, Large, Biotechnology, Small, Medium, Large; By Therapeutic Area: Cardiovascular...
May 21, 2026
Small Molecule CMO and CDMO Market (By Product Type: Active Pharmaceutical Ingredients, Finished Drug Products; By Drug Type: Innovators, Generics; By Therapeutic Area: Oncology, Neurology/CNS; By Stage Type: Clinical Phase, Commercial Manufactu...
April 21, 2026
According to market projections, the global albumin pharma market, valued at USD 6.77 billion in 2024, is anticipated to reach USD 11.72 billion by 2034, growing at a CAGR of 5.65% over the next decade. The rising prevalence of chronic diseases such ...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
April 21, 2026
According to market projections, the global liver disease therapeutics market, valued at USD 26.54 billion in 2025, is anticipated to reach USD 45.25 billion by 2035, growing at a CAGR of 5.48% over the next decade. The liver disease therapeutics mar...
February 16, 2026
According to market projections, the digital therapeutics sector is expected to grow from USD 9.84 billion in 2025 to USD 114.37 billion by 2035, reflecting a CAGR of 27.8%. The market is growing due to the rising need for effective, remote healthcar...
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited ...
February 26, 2026
Market insights predict, the RNA therapeutics and vaccines industry is expected to grow from USD 0.39 billion in 2025 to USD 205.34 billion by 2035, driven by a CAGR of 87%. The RNA therapeutics and vaccines market is growing as it is an innovative a...
April 21, 2026
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest ...
February 17, 2026
The global cystic fibrosis therapeutics market expected to reach USD 44.72 billion by 2035, growing at a CAGR of 14.24% over the forecast period. In 2024, North America dominated the market, while Asia-Pacific is set for the fastest growth. CFTR modu...
April 21, 2026
According to market projections, the protein therapeutics market sector is expected to grow from USD 375.3 billion in 2024 to USD 740.07 billion by 2034, reflecting a CAGR of 7.08%. The protein therapeutics market is expanding due to increasing disea...
April 21, 2026
Forecasts suggest that the synovial sarcoma treatment market will expand from USD 852.36 million in 2024 to USD 1214 million by 2034, with a CAGR of 3.6% during this period. In 2023, surgery remained the leading treatment, holding a dominant 56% mark...
April 21, 2026
Projections indicate that, the global allergy diagnostics and therapeutics market will increase from USD 36.55 billion in 2025 to USD 84.59 billion by 2035, experiencing a CAGR of 8.76% over the next 10 years. The market is growing due to the rising ...
April 21, 2026
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COP...
July 06, 2026
Market insights predict the global RNAi therapeutics industry will increase from USD $1.69 billion in 2026 to USD $5.90 billion by 2035, achieving a CAGR of 14.9%. In 2023, siRNA therapy dominated with a 64% market share, leading the RNA-based t...
May 26, 2026
Virus Removal Filter System Market (By Product Type: Consumables, Instruments; By Technology: Ultrafiltration, Nanofiltration, Reverse Osmosis, Microfiltration; By Application: Biopharmaceutical & Biotechnology, Medical Devices, Water Purificatio...
May 20, 2026
mRNA CDMO Service Market (By Application: C Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies; By Indication: Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases; By End-use: Biotec...
April 21, 2026
Based on market forecasts, the stroke diagnostics and therapeutics sector will expand from USD 38.03 billion in 2024 to USD 76.23 billion by 2034, experiencing a CAGR of 7.2%. Stroke diagnostics and therapeutics focus on quickly identifying and treat...
April 13, 2026
Peptide Therapeutics Market(By Type: Branded Peptide Drugs, Generic Peptide Drugs, By Route of Administration: Parenteral, Oral, Transdermal & Others, By Application/Therapeutic: Area Oncology, Metabolic Disorders, Infectious Diseases, Cardiov...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alc...
April 21, 2026
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
April 21, 2026
Market insights predict the global antisense and RNAi therapeutics industry will increase from USD 6.19 billion in 2024 to USD 35.63 billion by 2034, achieving a CAGR of 19.12%. Funding for research and development of rare diseases is promoting the m...
April 17, 2026
Biosimilar Contract Manufacturing Market (By Source: Mammalian, Non-mammalian; By Services: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins; By Therapeutic Area: Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic ...
May 26, 2026
Prescription Digital Therapeutics Market (By Application: Substance Use Disorder, Diabetes Management, Mental Health Disorders, Neurological Disorders, Cardiovascular Diseases, Respiratory Diseases, Obesity & Metabolic Disorders, Obesity & Me...
April 23, 2026
Digital Therapeutics for Mental Health Market (By Product Type: Software-Based Digital Therapeutics, Hardware-Based Digital Therapeutics; By Application: Depression, Anxiety, Substance Use Disorders, Cognitive Disorders, Post-Traumatic Stress Disorde...
April 21, 2026
The gene-editing therapeutics market is expanding due to growing advancements in gene editing technologies as well as their increasing applications. North America led the market due to the presence of the largest cluster of sponsors. ...
April 21, 2026
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive th...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
April 23, 2026
Hereditary Angioedema Therapeutics Market (By Drug Class: C1 Esterase Inhibitors, Kallikrein Inhibitors, Bradykinin B2 Receptor Antagonists, Others; By Route of Administration: Intravenous, Subcutaneous, Oral; By Treatment Type: On-demand Treatment, ...
April 16, 2026
Aptamers Market (By Type: Nucleic Acid Aptamer, Peptide Aptamer; By Application: Diagnostics, Therapeutics, Research & Development, Others; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Si...
May 18, 2026
Targeted Protein Degradation Therapy Market (By Technology: Proteolysis Targeting Chimeras (PROTACs), Autophagy-based Degradation, Molecular Glues, Other Technologies; By Target Disease: Cancer, Neurodegenerative Diseases, Autoimmune Diseases, Infect...
April 21, 2026
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy...
May 22, 2026
Small Molecules Market (By Product Lifecycle: Patented/Innovator Small-Molecule Brands, Generics, OTC/Non-prescription; By Therapeutic Area: Oncology, Cardiometabolic, CNS/Psychiatry & Neurology, Infectious Diseases, Respiratory & Allergy, Ga...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
June 25, 2026
According to Rohan Patil, who specializes in biotechnology, biopharmaceuticals, and life sciences markets, with 5+ years of experience in market research and industry analysis. My research indicates that the biotherapeutics market is set to expand fr...
April 24, 2026
Induced Proximity Molecules Market (By Molecule Type: PROTACs, Molecular Glues, LYTACs, AUTACs & ATTECs; By Target Protein Class: Kinases, Transcription Factors, Epigenetic Proteins, GPCRs & Membrane Proteins, Others; By Therapeutic Area: Onc...
April 21, 2026
The single-cell biotherapeutics market is growing because single-cell technologies have accomplished significant achievements in diagnosing and treating different tumors, such as breast tumors, lung tumors, and gliomas....
April 21, 2026
According to market projections, the digital psychotherapeutics sector is expected to grow from USD 1.69 billion in 2024 to USD 20.66 billion by 2034, reflecting a CAGR of 28.24%. In 2024, North America led the digital psychotherapeutics market. Asia...
+1 9197 992 333
+91 93077 85324
